Avita Medical | Le Coût Des Ventes



Cost Of Sales Changement Date
Adcock Ingram Holdings ZAR 3.29B 163.08M 2024-06
Celltrion KRW 418.52B 88.39B 2024-09
Clinuvel Pharmaceuticals AUD 1.93M 4.97M 2024-06
Cochlear AUD 269.9M 300K 2024-06
CSL USD 3.41B 315M 2024-06
Cspc Pharmaceutical CNY 2.07B 71.26M 2024-09
Ecofibre AUD 5.55M 761K 2024-06
Kangmei Pharma CNY 1.21B 124.7M 2024-09
Knight Therapeutics CAD 47.25M 990K 2024-09
Laboratorios Farma EUR 152.05M 84.2M 2024-12
Malin Corporation EUR 15.4M 0 2020-12
Mayne Pharma AUD 43.74M 2.67M 2024-06
Medical Developments International AUD 2.35M 1.73M 2024-06
Nanosonics AUD 10.69M 5.5M 2024-06
Organigram Holdings CAD 41.68M 69.31M 2024-12
Pacific Edge 280K 0 2024-03
Paradigm Biopharmaceuticals AUD 8.99K 8.99K 2024-06
Pharma Mar EUR 1.31M 696K 2024-12
Polynovo AUD 4.77M 2.77M 2024-06
PYC Therapeutics AUD 3.1M 2.8M 2020-12
Qiagen NV USD 187.91M 16.67M 2024-12
Ramsay Health Care AUD 2.23B 6.3M 2024-12
ResMed USD 530.81M 23.52M 2024-12
Sartorius EUR 452M 60.2M 2025-03
Sino Biopharmaceutical CNY 2.49B 1.07B 2024-12
Telix Pharmaceuticals AUD 148.66M 10.4M 2024-12
Tilray USD 149.73M 9.39M 2024-11
Zz Pientze Pharmaceu 1.49B 37.2M 2024-09



Avita Medical Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.